Anti-PRADC1 antibodies are used in the immunodetection of the protein protease associated domain containing 1. In humans, the canonical protein has a reported length of 188 amino acid residues and a mass of 21 kDa. It has been described to be a secreted protein. It is reported to be highly expressed in skeletal muscle, heart and liver. PRADC1 is reported to play a role in the modulation of physical activity and adiposity. Post-translational modifications have been described, including N-glycosylation. Synonyms for this target antigen include protease-associated domain-containing glycoprotein 21 kDa, protease-associated domain-containing protein of 21 kDa, and protease-associated domain-containing protein 1. PRADC1 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. Immunocytochemistry is the most common application for the PRADC1 antibodies listed below. Western Blot, Immunofluorescence, and Immunohistochemistry are also common applications.